Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucie Hamel

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
The Journal of Urology|May 18, 2013
Endoscopic vascular targeted photodynamic therapy with the photosensitizer WST11 for benign prostatic hyperplasia in the preclinical dog modelSimone Chevalier, Fabio L Cury, Eleonora Scarlata, et al.
International Journal of Molecular Sciences|June 26, 2025
Refined Procedure to Purify and Sequence Circulating Cell-Free DNA in Prostate CancerSamira Rahimirad, Seta Derderian, Lucie Hamel, et al.
British Journal of Cancer|February 3, 2017
Asporin is a stromally expressed marker associated with prostate cancer progressionAnnie Rochette, Nadia Boufaied, Eleonora Scarlata, et al.
Molecular Oncology|January 22, 2025
Clinical significance of stratifying prostate cancer patients through specific circulating genesSeta Derderian, Edouard Jarry, Arynne Santos, et al.
Oncogene|April 12, 2022
Fatty acid oxidation enzyme Δ3, Δ2-enoyl-CoA isomerase 1 (ECI1) drives aggressive tumor phenotype and predicts poor clinical outcome in prostate cancer patientsYogesh M Bramhecha, Karl-Philippe Guérard, Étienne Audet-Walsh, et al.
British Journal of Cancer|April 10, 2023
A DNA copy number alteration classifier as a prognostic tool for prostate cancer patientsWalead Ebrahimizadeh, Karl-Philippe Guérard, Shaghayegh Rouzbeh, et al.
Genes & Development|July 21, 2017
Nuclear mTOR acts as a transcriptional integrator of the androgen signaling pathway in prostate cancerÉtienne Audet-Walsh, Catherine R Dufour, Tracey Yee, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
The Journal of Urology|May 18, 2013
Endoscopic vascular targeted photodynamic therapy with the photosensitizer WST11 for benign prostatic hyperplasia in the preclinical dog modelSimone Chevalier, Fabio L Cury, Eleonora Scarlata, et al.
International Journal of Molecular Sciences|June 26, 2025
Refined Procedure to Purify and Sequence Circulating Cell-Free DNA in Prostate CancerSamira Rahimirad, Seta Derderian, Lucie Hamel, et al.
British Journal of Cancer|February 3, 2017
Asporin is a stromally expressed marker associated with prostate cancer progressionAnnie Rochette, Nadia Boufaied, Eleonora Scarlata, et al.
Molecular Oncology|January 22, 2025
Clinical significance of stratifying prostate cancer patients through specific circulating genesSeta Derderian, Edouard Jarry, Arynne Santos, et al.
Oncogene|April 12, 2022
Fatty acid oxidation enzyme Δ3, Δ2-enoyl-CoA isomerase 1 (ECI1) drives aggressive tumor phenotype and predicts poor clinical outcome in prostate cancer patientsYogesh M Bramhecha, Karl-Philippe Guérard, Étienne Audet-Walsh, et al.
British Journal of Cancer|April 10, 2023
A DNA copy number alteration classifier as a prognostic tool for prostate cancer patientsWalead Ebrahimizadeh, Karl-Philippe Guérard, Shaghayegh Rouzbeh, et al.
Genes & Development|July 21, 2017
Nuclear mTOR acts as a transcriptional integrator of the androgen signaling pathway in prostate cancerÉtienne Audet-Walsh, Catherine R Dufour, Tracey Yee, et al.
Pageof 2